PMGC Holdings Inc.
PMGC Holdings Inc. (ELAB) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for PMGC Holdings Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Exchange
- Nasdaq
- CEO
- Graydon Bensler
- Employees
- 2
- IPO date
- 21 Nov 2023
- ISIN
- US73017P4090
- Website
- pmgcholdings.com
Frequently asked questions
Where is PMGC Holdings Inc. stock listed?
PMGC Holdings Inc. (ELAB) is listed on Nasdaq.